DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Visual Pathway Disorder - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Visual Pathway Disorder (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline where reactions include visual pathway disorder. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cabergoline side effects in 30 year old male

Reported by a physician from France on 2012-03-30

Patient: 30 year old male

Reactions: Visual Field Defect, Condition Aggravated, Visual Pathway Disorder

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-30

Patient: 57 year old male

Reactions: Visual Field Defect, Visual Acuity Reduced, Condition Aggravated, Visual Pathway Disorder

Drug(s) suspected as cause:
Cabergoline

Other drugs received by patient: Testosterone Enanthate



Possible Cabergoline side effects in 36 year old male

Reported by a health professional (non-physician/pharmacist) from India on 2012-01-03

Patient: 36 year old male

Reactions: Brain Herniation, Visual Acuity Reduced, Visual Pathway Disorder, Convulsion

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in

Reported by a physician from France on 2011-11-18

Patient:

Reactions: Visual Field Defect, Visual Pathway Disorder, Toxicity To Various Agents

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg/week

Cabergoline
    Dosage: 3 mg/week
    Indication: Prolactinoma



Possible Cabergoline side effects in

Reported by a physician from France on 2011-11-18

Patient:

Reactions: Visual Pathway Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in

Reported by a physician from France on 2011-11-18

Patient:

Reactions: Visual Pathway Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in

Reported by a physician from France on 2011-11-18

Patient:

Reactions: Visual Field Defect, Toxicity To Various Agents, Visual Pathway Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 3 mg/week
    Indication: Prolactinoma

Cabergoline
    Dosage: 0.5 mg/week



Possible Cabergoline side effects in

Reported by a physician from France on 2011-11-16

Patient:

Reactions: Visual Field Defect, Toxicity To Various Agents, Visual Pathway Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg/week

Cabergoline
    Dosage: 0.5 mg/week
    Indication: Prolactinoma

Bromocriptine Mesylate
    Dosage: 2.5 mg, / day
    Indication: Prolactinoma

Bromocriptine Mesylate
    Dosage: 2.5 mg/week

Other drugs received by patient: Levothyroxine Sodium



Possible Cabergoline side effects in

Reported by a individual with unspecified qualification from India on 2011-11-11

Patient:

Reactions: Brain Herniation, Visual Pathway Disorder

Drug(s) suspected as cause:
Cabergoline
    Dosage: 2 mg, per week

Cabergoline
    Dosage: 1 mg, per week
    Indication: Prolactinoma

Cabergoline
    Dosage: 3 mg, every week

Other drugs received by patient: Levothyroxine Sodium; Testosterone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017